Translate
Gh Research Plc
About
Gh Research Plc (NASDAQ:GHRS) — investor relations, events, news, and company updates on 6ix.
Latest News
Yesterday
GH Research Announces Pricing of $117.5 Million Underwritten Offering
Apr 20 2026
GH Research Welcomes White House Executive Order to Accelerate Medical Treatments for Serious Mental Illness
Mar 25 2026
GH Research Announces Publication of Phase 2b Results for Mebufotenin (GH001) in JAMA Psychiatry and Reports New Finding of Severity-Independent Efficacy in TRD
Mar 5 2026
GH Research Reports Full Year 2025 Financial Results and Provides Business Update
Jan 5 2026
GH Research Announces FDA Lifts Clinical Hold on GH001, Clearing Path for Global Phase 3 Initiation in 2026
Recent Videos
How to Invest in GH Research PLC (GHRS) Step by Step
Apr 12, 2026
GH Research Stock Analysis | 5-MeO-DMT Lead Drug Could Disrupt Psychiatry
Mar 07, 2026
GH 리서치(GH Research, GHRS) ‘시간외 급등’…FDA IND 업데이트 예고가 뭐길래?
Jan 03, 2026
Doing some GH research in the wake of the Lattice fall out
Dec 03, 2025
Financials
Revenue
$0
Market Cap
$903.77 M
EPS
-0.79